BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$928M |
| 2 |
Amazon
AMZN
|
+$700M |
| 3 |
Apple
AAPL
|
+$206M |
| 4 |
iShares MSCI Japan ETF
EWJ
|
+$204M |
| 5 |
Tesla
TSLA
|
+$159M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$492M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$407M |
| 4 |
Motorola Solutions
MSI
|
+$327M |
| 5 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$317M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.42% |
| 2 | Consumer Discretionary | 6.24% |
| 3 | Financials | 5.68% |
| 4 | Healthcare | 5.01% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FRBK
3501
DELISTED
Republic First Bancorp Inc
FRBK
| $83.7K | ﹤0.01% |
22,509
+9,717
| +76% | +$32.6K |
|
3502
Suburban Propane Partners
SPH
$1.17B
| $83.2K | ﹤0.01% |
+5,681
| New | +$86K |
|
3503
Ceco Environmental
CECO
$4.5B
| $83.1K | ﹤0.01% |
13,334
+5,010
| +60% | +$33.2K |
|
3504
Atossa Therapeutics
ATOS
$25.5M
| $81.8K | ﹤0.01% |
3,408
+1,599
| +88% | +$58.5K |
|
|
MRLN
3505
DELISTED
Marlin Business Services Corp
MRLN
| $81.7K | ﹤0.01% |
3,508
+1,264
| +56% | +$28.8K |
|
3506
KT
KT
$9.03B
| $81.4K | ﹤0.01% |
6,472
| – | – |
|
3507
Apyx Medical
APYX
$128M
| $81.1K | ﹤0.01% |
6,327
+882
| +16% | +$12.3K |
|
3508
Flexsteel Industries
FLXS
$303M
| $81.1K | ﹤0.01% |
3,018
+1,100
| +57% | +$31.6K |
|
3509
VistaGen Therapeutics
VTGN
$11.8M
| $81K | ﹤0.01% |
1,385
+218
| +19% | +$14.2K |
|
3510
Oaktree Specialty Lending
OCSL
$1.15B
| $80.6K | ﹤0.01% |
+3,600
| New | +$79.7K |
|
3511
Blue Bird Corp
BLBD
$2.05B
| $80.1K | ﹤0.01% |
5,123
+1,234
| +32% | +$24.5K |
|
3512
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.3B
| $79.5K | ﹤0.01% |
+933
| New | +$78.2K |
|
3513
Duluth Holdings
DLTH
$151M
| $78.7K | ﹤0.01% |
5,187
+2,761
| +114% | +$41.7K |
|
|
ONCT
3514
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $78K | ﹤0.01% |
1,719
+1,184
| +221% | +$79.7K |
|
3515
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.75B
| $77.8K | ﹤0.01% |
+1,363
| New | +$77.3K |
|
|
CNCE
3516
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $77.3K | ﹤0.01% |
24,534
+24,426
| +22,617% | +$81.3K |
|
3517
iShare MSCI Eurozone ETF
EZU
$9.96B
| $77K | ﹤0.01% |
+1,571
| New | +$77.4K |
|
|
AC
3518
DELISTED
Associated Capital Group
AC
| $75.3K | ﹤0.01% |
1,750
+1,288
| +279% | +$51.1K |
|
|
XNET
3519
Xunlei
XNET
$328M
| $74.9K | ﹤0.01% |
+37,276
| New | +$97.7K |
|
|
TBCH
3520
Turtle Beach Corp
TBCH
$230M
| $74.7K | ﹤0.01% |
3,357
+235
| +8% | +$6.34K |
|
3521
Harvard Bioscience
HBIO
$30.4M
| $74.5K | ﹤0.01% |
1,056
+301
| +40% | +$21.4K |
|
3522
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.61B
| $74.3K | ﹤0.01% |
+1,183
| New | +$74.6K |
|
3523
Grupo Aeroportuario del Sureste
ASR
$8.01B
| $74K | ﹤0.01% |
359
| – | – |
|
3524
NVE Corp
NVEC
$563M
| $72.9K | ﹤0.01% |
1,067
+168
| +19% | +$11.5K |
|
3525
Verastem
VSTM
$604M
| $72.8K | ﹤0.01% |
2,958
-11,182
| -79% | -$353K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2021 Portfolio in Review
As of Q4 2021, BNP Paribas Financial Markets held 4,341 positions worth $70.2B, down 0.46% from $70.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
BNP Paribas Financial Markets withdrew a net $5.34B in Q4 2021, closing 139 positions and reducing 1,467 holdings. Its most notable exit was HILL-ROM HOLDINGS, INC., an estimated $23.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 10% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, BNP Paribas Financial Markets opened a new position in Invesco S&P 500 Equal Weight ETF worth $33M.
- BNP Paribas Financial Markets's largest Q4 2021 buy was Invesco S&P 500 Equal Weight ETF: 202,625 shares worth $33M.
- BNP Paribas Financial Markets added most to Microsoft in Q4 2021, an estimated $928M increase.
- BNP Paribas Financial Markets's biggest Q4 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $1.21B.
- BNP Paribas Financial Markets fully exited HILL-ROM HOLDINGS, INC. in Q4 2021, selling an estimated $23.5M.
- BNP Paribas Financial Markets's ten largest holdings make up 13% of its $70.2B portfolio in Q4 2021.
- BNP Paribas Financial Markets opened 329 new positions and closed 139 in Q4 2021.
- BNP Paribas Financial Markets's portfolio value fell 0.46% quarter-over-quarter to $70.2B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2021, filed 9 Feb 2022.